Yale-Mayo Clinic CERSI Scholar Virtual Research Seminar 2026

Introductions Molly Jeffery, PhD and Joseph Ross, MD, MHS (Yale-Mayo Clinic CERSI) Keynote Address: Presented by Joyce Obidi, PhD, PMP (Health Programs Coordinator, Scientific Programs FDA Office of Women’s Health) Scholar Presentations Session 1: Systematic Evaluation of Clinical Validity of Digital Endpoints used in Clinical Trials (Rohini Ghosh, Yale) Cross-Sectional Technical Audit of Data Streams in mHealth Applications Recommended by ORCHA and Available in France and the United States (Victor Montori, Mayo Clinic) Use of the Sentinel ARIA System in Addressing Safety Concerns Identified During Premarket Review of New Drugs and Biologics, 2016-2025 (Erfan Taherifard, Yale) From FDA Approval to Real-World Safety: Biologic Use and Infection Risk in Children with Inflammatory Bowel Disease (Ning Lyu, Harvard) Gene Regulation Underlying Chemotherapy-Induced Peripheral Neuropathy (Thu Pham, UCSF) Session 2: Developing Novel Bayesian Semiparametric Change-Plane Regression for Subgroup Identification in Regulatory Science (Yuki Ohnishi, Yale) Utilizing the UNC Clinical Data Warehouse for Assessing Efficacy, Toxicity, and Dose-Response Relationships of Molecularly Targeted Therapies in Real-World Patients (Viet Dang, UNC) Toward a New Generation of Causal Hazard Ratio: A Bayesian Machine Learning Approach for Survival Analysis (Ruyi Liu, Yale) Solution Blow Spun Polymer Fiber Mat Degradation and Biocompatibility in the Female Reproductive Tract (Robert Morris, UMD) Session 3: Evaluating User Experience to Advance Implementation and Regulation of AI Voice Technologies in Clinical Practice (Taylor Harrison, Mayo Clinic) Public Participation in U.S. Food and Drug Administration (FDA) Advisory Committees: A Qualitative Analysis (Caleigh Propes, JHU) Assessment of The Prescription Drug User Fee Act Commitment Letters (Therese Ziaks, Yale) Brand Name Extensions Among OTC Drugs (Kanhai Amin, Yale)